KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ALDR
Delisted

Alder BioPharmaceuticals Stock Price (Quote)

$18.88
+0 (+0%)
At Close: Apr 15, 2020

Range Low Price High Price Comment
30 days $18.88 $18.88 Wednesday, 15th Apr 2020 ALDR stock ended at $18.88. During the day the stock fluctuated 0% from a day low at $18.88 to a day high of $18.88.
90 days $18.88 $18.88
52 weeks $8.39 $19.12

Historical Alder BioPharmaceuticals prices

Date Open High Low Close Volume
May 23, 2019 $10.96 $11.08 $10.81 $11.01 472 645
May 22, 2019 $11.26 $11.34 $10.87 $11.12 716 585
May 21, 2019 $10.86 $11.39 $10.52 $11.35 1 410 043
May 20, 2019 $10.71 $10.83 $10.40 $10.46 824 758
May 17, 2019 $10.86 $11.07 $10.63 $10.83 643 297
May 16, 2019 $11.00 $11.25 $10.93 $10.98 1 133 701
May 15, 2019 $10.84 $11.06 $10.76 $10.95 1 069 664
May 14, 2019 $10.66 $10.98 $10.65 $10.92 1 157 358
May 13, 2019 $11.05 $11.22 $10.61 $10.65 1 049 185
May 10, 2019 $11.57 $11.73 $11.14 $11.35 952 860
May 09, 2019 $11.82 $12.05 $11.51 $11.69 858 912
May 08, 2019 $12.02 $12.20 $11.75 $11.98 1 216 801
May 07, 2019 $12.52 $12.56 $11.75 $12.01 1 001 807
May 06, 2019 $11.91 $12.74 $11.91 $12.67 2 078 121
May 03, 2019 $12.30 $12.37 $11.70 $12.28 1 616 705
May 02, 2019 $12.30 $12.75 $11.95 $12.24 1 454 422
May 01, 2019 $13.59 $13.65 $12.43 $12.44 1 216 168
Apr 30, 2019 $13.70 $13.96 $13.27 $13.59 2 124 242
Apr 29, 2019 $13.95 $14.11 $13.66 $13.68 460 373
Apr 26, 2019 $13.99 $14.20 $13.57 $13.96 942 218
Apr 25, 2019 $13.65 $14.11 $13.44 $14.00 664 963
Apr 24, 2019 $13.90 $14.15 $13.30 $13.68 1 188 640
Apr 23, 2019 $12.81 $13.82 $12.80 $13.75 1 464 505
Apr 22, 2019 $12.64 $12.96 $12.50 $12.76 368 975
Apr 18, 2019 $12.87 $12.97 $12.49 $12.68 1 180 381
Click to get the best stock tips daily for free!

About Alder BioPharmaceuticals

Alder BioPharmaceuticals Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States and Australia. The company’s lead product candidate ALD403, an antibody, which is in Phase II clinical trial to target calcitonin gene-related peptide for the prevention of migraine. It also develops ALD1613, which is in preclinical stage to treat patients with congenital adrenal hyperpla... ALDR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT